America's Weighty Burden: How Obesity is Crippling the U.S. Economy

The Global Controversy: Is a Blockbuster Drug Fueling Scientific Colonialism?

Eli Lilly Unveils $1 Billion India Investment to Supercharge Mounjaro Production

The Truth Behind Transformative Weight Loss: Unpacking the GLP-1 Phenomenon

Unmasking the Hidden Health Crisis: Why 'Thin-Fat' Indians Redefine Obesity and the Promise of GLP-1 Drugs

The Race for the Next Weight Loss Breakthrough: Chinese Biotechs Challenge Global Giants

Ozempic and GLP-1 Drugs: Unveiling the Hidden Pregnancy Risks Under Intense Scrutiny

A New Era in Health: WHO Adds Mounjaro and Ozempic to Essential Medicines List

Wegovy Triumphs: Novo Nordisk's Obesity Drug Significantly Cuts Heart Attack and Stroke Risk, Setting a New Benchmark in Cardiovascular Protection

UK Healthcare on Edge: Mounjaro Shortages Loom as Eli Lilly's Price Hike Sparks Patient Panic

The Silent Scourge: Why GLP-1 Drugs Like Ozempic Might Be Hiding a Dental Disaster

The Alarming Truth About 'Ozempic Teeth': Dentists Sound the Alarm on GLP-1 Side Effects

The Wild West of Weight Loss: Unpacking the Perils of Online Compounded GLP-1s